Congenital adrenal hyperplasia (CAH) is a genetic disorder and the most severe form of the disease can lead to a life threatening condition during the first weeks of life. The disease is caused by enzyme defects in steroid biosynthesis, the most frequent types being 21- and 11α-hydroxylase deficiency.
false falsePlease enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
These types represent 95% of CAH cases and in both, the 17α-OH progesterone (17OHP), a precursor of cortisol, is increased. The determination of 17OHP is thus a useful screening method for 95% of all CAH cases.
GSP Neonatal 17α-OH-progesterone assay
The GSP Neonatal 17α-OH-progesterone assay is intended for the quantitative determination of 17OHP in dried blood spot specimens as an aid in screening newborns for CAH.
| Assay Technology | DELFIA |
|---|---|
| Calibration Standards | Yes |
| Capacity Load Throughput | 12 plates |
| Detection Method | DELFIA |
| Disorders | Congenital Adrenal Hyperplasia (CAH) |
| Product Brand Name | GSP® |
| Sample Type | Dried blood spots |
